About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Philadelphia | 449 Studies

Clinical Trials LymphomaPhiladelphia

Lymphoma Clinical Trials in Philadelphia

Find 449 clinical trials for lymphoma near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 449 trials

CompletedStudy of Efficacy and Safety of CTL019 in Adult DLBCL PatientsThis is a multi-center, phase II study to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory DLBCL.NCT02445248·San Francisco, California and 25 others CompletedA Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesThis phase II trial studies how well reduced intensity donor stem cell transplant works in treating patients with hematologic malignancies.NCT01384513·Philadelphia, Pennsylvania

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedMobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsThe purpose of this study is to determine whether the combination of AMD3100 (plerixafor) and granulocyte colony-stimulating factor (G-CSF or generic name filgrastim) is better…NCT00103610·Phoenix, Arizona and 31 others

Active not recruitingCombination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic LeukemiaThis phase II trial is studying the side effects of giving combination chemotherapy together with or without donor stem cell transplant and to see how well it works in treating…NCT00792948·Tucson, Arizona and 156 others

TerminatedEarly FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on LenalidomideAdult patients with non-Hodgkin lymphoma who will be treated with lenalidomide will undergo FDG PET/CT scan as an early evaluation of response to therapy.NCT03065790·Philadelphia, Pennsylvania

CompletedA Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell LymphomaThis is a Phase I Trial to assess the feasibility of Romidepsin combined with Brentuximab Vedotin for patients requiring Systemic Therapy for Cutaneous T-cell Lymphoma.NCT02616965·Philadelphia, Pennsylvania and 1 other

CompletedBelinostat in Relapsed or Refractory Peripheral T-Cell LymphomaThe purpose of this study is to assess efficacy and safety of belinostat in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL), who failed at least one…NCT00865969·Duarte, California and 116 others

TerminatedPilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic LeukemiaThis is a single center, single arm, open-label pilot study to determine the feasibility and safety of a single dose of autologous T cells expressing CD22 chimeric antigen…NCT02588456·Philadelphia, Pennsylvania

CompletedSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantThis randomized phase III trial is studying how well Caphosol rinse works in preventing mucositis in young patients undergoing autologous or donor stem cell transplant.NCT01305200·Arcadia, California and 34 others

TerminatedA Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell TransplantationHigh-dose chemotherapy followed by blood stem cell transplantation is administered to lymphoma patients with an intention to cure.NCT05181540·Gilbert, Arizona and 27 others

RecruitingTesting Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerThis phase III trial compares the effect of vorasidenib to placebo in combination with usual treatment, temozolomide, in treating patients with newly diagnosed grade 3 astrocytoma…NCT07215910·Bakersfield, California and 151 others

CompletedStudy of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell LymphomaThis is a Phase 1, multi-center, open-label study of TRPH-222 monotherapy in subjects with relapsed and/or refractory B-cell NHL.NCT03682796·Gilbert, Arizona and 6 others

Active not recruitingCombination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaThis randomized phase III trial studies combination chemotherapy with blinatumomab to see how well it works compared to induction chemotherapy alone in treating patients with…NCT02003222·Birmingham, Alabama and 543 others

Active not recruitingStudy of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of EpcoritamabThe most common types of mature B-cell lymphomas (MBLs) in children are Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL).NCT05206357·Palo Alto, California and 40 others

TerminatedA Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin LymphomaThe study will examine the safety profile of SGN-CD19B administered as a single agent.NCT02702141·Birmingham, Alabama and 15 others

UnknownNM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT)In the proposed study, NM-IL-12 will be evaluated as immunotherapy to increase antitumor efficacy against CTCL, while reducing skin-related toxicity, when combined with low-dose…NCT02542124·Stanford, California and 2 others

Active not recruitingStudy of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive PatientsThis is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in de novo HR pediatric and young adult B-ALL patients who…NCT03876769·Birmingham, Alabama and 42 others

RecruitingSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Substudy 01A is part of a platform study.NCT06395103·Los Angeles, California and 70 others

CompletedBortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin LymphomaRATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the cancer.NCT00598169·La Jolla, California and 16 others

CompletedRituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00075946·Scottsdale, Arizona and 482 others

PreviousPage 18 of 23Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia